Cannabis plant may play a role in treating chronic inflammation

Credit: Unsplash+.

In a recent study from The Queen’s Medical Center and the University of Hawaii, scientists found several minor cannabinoids contained in the cannabis plant “strongly inhibit” the activation of human immune cells that lead to chronic inflammation.

The study also revealed the strongest inhibitory cannabinoid, cannabigerolic acid, disrupts a key mechanism that allows calcium ions to enter and activate immune cells.

As a result, cannabigerolic acid suppresses the spread of inflammatory signals.

Chronic inflammation is a biological process in which inflamed tissues release messenger molecules called cytokines.

These cytokines recruit immune cells that become activated and maintain the inflammatory response. This chronic inflammation initiates or exacerbates numerous human disease conditions.

The team says cannabigerolic acid, either alone or in combination with other cannabinoids, may be a key ingredient in medicines that work to break the inflammatory cycle that maintains autoimmune diseases and chronic pain.

This could lead to targeted and more specific anti-inflammatory and anti-pain treatments without the risk of serious side effects often encountered with steroids, or non-steroidal anti-inflammatory drugs, or opioids.

If you care about Marijuana, please read studies that marijuana users need up to 220% higher dosage for sedation in surgeries, and Marijuana may strongly increase death risk in high blood pressure.

If you care about wellness, please read studies that vegetarian women have higher risk of hip fracture, and these vitamins could help reduce bone fracture risk.

The study was conducted by Reinhold Penner et al and published in Function.

Copyright © 2023 Knowridge Science Report. All rights reserved.